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Six Buschke-Lowenstein tumors, i.e., highly differentiated squamous cell tumors of the genital region, were
shown to contain human papillomavirus 6 (HPV 6) or HPV 11 genomes. The viral DNA was found in an
episomal state, including a very small fraction of circular oligomers. HPV 6a and HPV 6d genomes were cloned
from two of the tumors. Comparison with HPV 6b, cloned from a benign genital wart (E.-M. de Vflliers, L.
Gissmann, and H. zur Hausen, J. Virol. 40:932-935, 1981) by restriction mapping and partial sequence
analysis, revealed a very high degree of homology with the different HPV 6 subtypes. A tandem duplication of
459 base pairs within the noncoding region of the genome was found in the new subtype HPV 6d. This
structural rearrangement in a region containing the putative control elements for early gene transcription
might influence the biological potential of that virus. No evidence for rearrangement of this region was found
in the HPV DNA from the five other tumors.
It is well established that benign genital warts (con-
dylomata) are caused by human papillomaviruses (HPV):
HPV type 6 (HPV 6) or HPV 11 can be detected in over 90%
of these lesions (9, 12), and very recently, it has been shown
that in vitro infection of human cervical tissue explants with
these HPV types elicited a histological picture typical for
genital warts (14). Buschke-Lowenstein tumors or giant
condylomata are large verrucous genital tumors which do
not metastasize (2), but clinically they are nevertheless
regarded as malignant (8). Histologically, they share many
features with condylomata acuminata, but ultrastructurally,
they show some Bowenoid features (13). It has been sug-
gested that the Buschke-Lowenstein tumor might be an
intermediate lesion within a continuous spectrum of biolog-
ically related tumors ranging from the condyloma to the
invasive squamous cell carcinoma (4, 17). Malignant genital
tumors and preneoplastic lesions are strongly associated
with HPV 16 and HPV 18, whereas HPV 6 and HPV 11 seem
to be mostly confined to benign condylomatous lesions (1, 6,
11). Exceptions seem to exist, however, as HPV 6 or HPV
11 DNA has been detected in a few Buschke-Lowenstein
tumors analyzed earlier (9, 15) and in six tumors reported in
this communication. Consequently, Buschke-Lowenstein
tumors and condylomata were analyzed for differences in the
structure or the physical state of HPV 6 and HPV 11 DNA
possibly linked to the biological properties of the corre-
sponding lesion.
Genomic DNA from six Buschke-Lowenstein tumor biop-
sies was subjected to Southern blot hybridizations with
cloned HPV 6, HPV 11, HPV 16, and HPV 18 as probes.
Extraction of genomic DNA from tumor tissue, gel el-
ectrophoresis and transfer, labeling of DNA, and hybridiza-
tion conditions for high and low stringency were done
exactly as described previously (1). All tumor DNAs were
positive for HPV 6 or HPV 11 sequences under high-
stringency conditions (Tm, - 18°C). The typical PstI cleavage
patterns ofHPV 6 and HPV 11 (12) and differential reactivity
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with the HPV 6 and HPV 11 probes (not shown) allowed
precise typing (Fig. 1). No additional signals were detected
when hybridizing under low-stringency conditions (Tm,
-40°C) with HPV 6 DNA (Fig. 1) or under high- and
low-stringency conditions with HPV 16 or HPV 18 DNA
(data not shown). Thus, it can be ruled out that the additional
presence of HPV 16 or HPV 18 within a primarily benign
HPV 6- or HPV 11-containing condyloma is responsible for
the more agressive growth properties of the Buschke-
Lowenstein tumors. One tumor (Fig. 1, lane 5) contained a
new subtype of HPV 6 with a slightly larger genome (HPV
6d).
The physical state ofHPV DNA was then analyzed in five
Buschke-Lowenstein tumors. After digestion of genomic
DNA with a one-cut restriction enzyme for HPV 6 and HPV
11, a single band could be visualized by Southern blot
hybridization, corresponding to linearized, 8-kilobase HPV
genomes (Fig. 2). The typical pattern of forms I, II, and III
of free episomal HPV genomes was visible in all tumor
DNAs after digestion with different noncut enzymes. Very
faint additional bands could be detected in the high-
molecular-weight region of the gel. They were, however,
identified as circular oligomers, as their size was identical in
all tumors; they disappeared completely after digestion with
a one-cut enzyme, and they could not be mobilized by
different noncut enzymes that are known to cleave fre-
quently within the human genome (Fig. 2). Thus, there was
no evidence for integration of viral sequences in the
Buschke-Lowenstein tumors investigated here.
The identification of a HPV 6 subtype with a larger
genome in one biopsy (HPV 6d; Fig. 1, lane 5) led to a
careful comparison of HPV 6 DNAs from Buschke-
Lowenstein tumors and benign condylomata. Therefore
HPV 6a and HPV 6d were cloned from the DNAs of two
tumors (Fig. 1, lanes 3 and 5, respectively). The viral DNAs
were first isolated from genomic libraries constructed in
phage vectors XL47 or EMBL 3, as described by Gissmann
et al. (10), and were then subcloned into pBR322. HPV 6b
had previously been cloned from a condyloma acuminatum
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FIG. 1. Typing of HPV DNA in six Buschke-Lowenstein tu-
mors. Genomic DNA was cut with Pstl, separated in 1% agarose
gels, transferred to a nitrocellulose filter and hybridized under
low-stringency conditions (Tm,, -40'C) with a nick-translated 32P-
labeled HPV 6b probe. The amount of DNA loaded per slot (2 to 20
p.g) was adjusted to get comparable signals in all lanes. The Pstl
cleavage patterns allowed distinction of different HPV 6 and HPV 11
subtypes (12). Lanes: 1, HPV lla; 2, HPV llc; 3, HPV 6a; 4, HPV
6a; 5, HPV 6d; 6, HPV 6a. A mixture of X HindIll-fragments and
PM2 HindIII-fragments was used as markers (23.7, 9.64, 6.64, 5.64,
4.33, 2.15, 1.04, 0.48, and 0.44 kilobases). Note the size difference
between the Pstl B fragments of HPV 6a (lanes 3, 4, and 6) and HPV
6d (lane 5) due to the tandem duplication of 459 bp within the HPV
6d genome (Fig. 3).
(5) and sequenced (18). The genomes of the three cloned
HPV 6 subtypes were linearized by BamHI cleavage, gel
purified from the vector sequences, and subjected to restric-
tion analysis with 13 different endonucleases, thus probing
for differences at 27 cleavage sites predicted by the HPV 6b
sequence. HPV 6b and HPV 6d differed at only 1 of the 27
sites, HPV 6a and HPV 6d differed at 3 sites, and HPV 6a
and HPV 6b differed at 4 sites, thus reflecting a very high
similarity of the HPV 6 subtypes (data not shown). The size
difference of HPV 6d relative to HPV 6a (Fig. 1) was
attributable to the insertion of about 460 base pairs (bp)
within the noncoding region of the HPV 6d genome. For
further analysis of that insertion, the cleavage sites of a
number of frequently cutting restriction enzymes were
mapped within the PstI B fragments of HPV 6a and HPV 6d.
These maps were compared with the corresponding part of
the HPV 6b genome, which includes the noncoding region.
The data confirmed conservation of almost all restriction
sites among subtypes and suggested duplication of about 460
bp within the noncoding region ofHPV 6d (Fig. 3). This part
of the noncoding region of HPV 6d was then sequenced by
the chemical method of Maxam and Gilbert (16), and an
exact tandem duplication of 459 bp, encompassing more than
half of the noncoding region, was found (positions 7528 to 84
[18]; Fig. 3). The sequence information obtained for HPV 6d
(a total of 634 bp) diverged only by two point mutations from
the HPV 6b sequence (position 7585, A -3 C; and position
7815, G -+ C). This underscores the high sequence homology
among HPV 6 subtypes. The FnuDIIIHinfl fragment span-
ning part of the noncoding region most proximal to the Li
open reading frame was found to be about 120 bp larger in
HPV 6a and HPV 6d than was predicted by the HPV 6b
sequence. The significance of this finding was questionable,
as rearrangements within the same fragment had frequently
been observed during the cloning procedures. To clarify this
point, a number of condylomata acuminata and Buschke-
Lowenstein tumors were reanalyzed, including the materials
from which HPV 6a, HPV 6b, and HPV 6d had been cloned.
The genomic DNAs were digested with Hinfl and subjected
to Southern blot analysis with a subgenomic fragment (PstI
B) of HPV 6 as probe, which covers the noncoding region.
As a result, no differences could be detected between
restriction fragments from the late side of the noncoding
regions of the HPV 6a, HPV 6b, and HPV 6d genomes in
tumors and condylomata and the corresponding fragments of
the cloned HPV 6a and HPV 6d DNA (data not shown). The
HPV 6b clone pAmp2 used for sequence analysis of that
region by Schwarz et al. (18) was, however, shown to bear a
deletion of about 120 bp (Fig. 3). This part of the genome is
very rich in alternating purine-thymidine nucleotides and
thus, cloning in Escherichia coli may result in deletions by
recA-independent recombination of short direct sequence
repetitions, according to a model proposed by Collins et al.
(3).
The presence of HPV 6 or HPV 11 and the episomal state
of the viral genomes clearly distinguish Buschke-Lowenstein
tumors from invasive genital carcinomas, which mostly
harbor integrated copies of HPV 16 or HPV 18 DNA (1, 6,
7). The tandem duplication of 459 bp within the noncoding
region of HPV 6d is of considerable interest as it duplicates
the putative control elements and start sites for early gene
transcription. Enhanced or deregulated early gene expres-
sion might be the consequence and could confer a higher
tumorigenic potential to a virus which usually induces be-
nign tumors (condylomata). A similar mechanism has been
evidenced for human papovavirus BK: in a number of BK
virus mutants which transform rodent cells much more
efficiently than wild type BK, sequence rearrangements
affecting the viral enhancer (68-bp repeat) within the noncod-
ing region of the genome have been found (19). These
rearrangements are responsible for the phenotype of the
mutants (19, 21), and, as far as was analyzed, deregulated,
continuous expression of early gene functions of the mutant
genomes was observed (20). There was no evidence for
structural alterations in the noncoding region of the viral
genomes from any other of the six Buschke-Lowenstein
tumors. Thus, in many cases host factors, rather than the
occurrence of specifically pathogenic viral variants, might
account for the rare development of a Buschke-Lowenstein
tumor as the final stage of a long-persisting genital infection
with HPV 6 or HPV 11. Impairment of cell-mediated immu-
nity, as well as the synergistic action of carcinogenic factors,
may play a role, as has been suggested for the development
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FIG. 2. Physical state of HPV DNA in Buschke-Lbwenstein tumors. Genomic DNA of five tumors was digested with BamHI (lanes, 1,
5, 9, 13, and 17), BclI (lanes 2, 6, 10, 14, and 18), BglII (lanes 3, 7, 11, 15, and 19), or SstI (lanes 4, 8, 12, 16, 20), separated in a 0.5% agarose
gel, transferred to a nitrocellulose filter, and hybridized under stringent conditions with nick-translated 32P-labeled HPV 6d DNA. Lanes 1
through 4 HPV lic DNA; lanes 5 through 8, HPV lla DNA; lanes 9 through 12, HPV 6d DNA; lanes 13 through 16 HPV 6a DNA; lanes 17
through 20, HPV 6a DNA. The positions of nicked circles (form II), linear molecules (form III), and covalently closed circles (form I) are
indicated by arrows. The amount of form I was low after digestion with BclI, due to a nicking activity in this enzyme preparation. X HindIII
fragments were used as markers.
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FIG. 3. Restriction maps of the PstI B fragments of HPV 6a and HPV 6d in comparison to the restriction map of the corresponding region
of HPV 6b as compiled from the sequence of Schwarz et al. (18). The open reading frames Li and E6 of HPV 6b are indicated by hatched
boxes, and the noncoding region between Li and E6 is emphasized by a bracket. The scale at the top of the figure gives the nucleotide
positions of HPV 6b. The tandem duplication of 459 bp in HPV 6d and the homologous sequence in HPV 6b are marked by arrows. The
corresponding segment of HPV 6a is also indicated, but has not been sequenced. Below, the PstI B fragment is shown as part of the circular
genome of HPV 6d. Sites: FnuDII (0), HaeII (*), Hinfl (U), HpaII (O), PstI (*), Sau3A (0).
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of cervical cancer (22). Lack of hygiene, long persistence of
genital HPV infection and inappropriate treatment have
repeatedly been pointed out as risk factors for Buschke-
Lowenstein tumors (8, 13).
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